Physician profile
Kofi Marfo Osei
NPI 1124469317
$86,707.71
in general payments reported to CMS, 2019-2025
17 companies · $8,634 in 2025
The $8,634 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $473 · 2021: $3,338 · 2022: $13K · 2023: $40K · 2024: $22K · 2025: $8,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $29K · Grant: $29K · Food and Beverage: $11K · Education: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $29,065.78 |
| Grant | $29,000.00 |
| Food and Beverage | $11,338.41 |
| Education | $435.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $37,336.58 | 2021-2025 | Corevalve Evolut R, Micra, Selectsecure |
| Abbott Laboratories | $13,966.91 | 2020-2025 | Ensite Precision, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Boston Scientific Corporation | $11,529.14 | 2022-2025 | Emblem Mri S-Icd, Ingevity+, Watchman Flx |
| Philips North America LLC | $10,253.61 | 2023-2025 | (9520) Igt Devices Undivided, Lm Undivided, (Bh4) Igt Devices Undivided |
| Biotronik INC. | $8,859.86 | 2022-2024 | Solia, Selectra, Pamira |
| Medical Device Business Services, INC. | $2,974.91 | 2022-2023 | Carto 3 |
| Biosense Webster, INC. | $423.57 | 2022-2024 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $393.83 | 2022-2025 | Lifevest |
| Medtronic Vascular, INC. | $277.08 | 2019 | |
| Astellas Pharma US INC | $198.00 | 2019 | |
| Amgen INC. | $134.21 | 2020 | |
| Abiomed | $125.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.46 | 2021 | |
| Cardiva Medical, INC. | $41.29 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $37.92 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.46 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kofi Osei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.